Evidence map›Paper›PMID 37287024›Full record

ArticleJournal of biomedical science2023

Akkermansia muciniphila and its membrane protein ameliorates intestinal inflammatory stress and promotes epithelial wound healing via CREBH and miR-143/145.

Henry Wade, Kaichao Pan, Qihua Duan, Szczepan Kaluzny, Ekta Pandey, Linda Fatumoju, Viswanathan Saraswathi, Rongxue Wu, Edward N Harris, Qiaozhu Su

Open access · diamondAbstract read
In one paragraph

Article in Journal of biomedical science, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 65 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
65citing papers in PubMed, 2 pooled it
13.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

65 citing papers in PubMed, 2 syntheses or guidelines pooled it, 85 citations in OpenAlex.

  1. Pooled it
  2. The role ofFrontiers in medicine · 2025
    Pooled it
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Unveiling the Molecular Repertoire ofJournal of microbiology and biotechnology · 2026
    Review
  12. Review
  13. Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Frontiers in microbiology · 2026
    Review

5 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Henry Wade *Institute for Global Food Security, School of Biological Sciences, Queen's University Belfast, Belfast, BT9 5DL, UK.
Kaichao Pan *Department of Medicine, Section of Cardiology, University of Chicago, Chicago, USA.
Qihua DuanInstitute for Global Food Security, School of Biological Sciences, Queen's University Belfast, Belfast, BT9 5DL, UK.
Szczepan KaluznyInstitute for Global Food Security, School of Biological Sciences, Queen's University Belfast, Belfast, BT9 5DL, UK.
Ekta PandeyDepartment of Biochemistry, University of Nebraska-Lincoln, Lincoln, NE, 68583, USA.
Linda FatumojuDepartment of Biochemistry, University of Nebraska-Lincoln, Lincoln, NE, 68583, USA.
Viswanathan SaraswathiUniversity of Nebraska Medical Center, Omaha, NE, 68198, USA.
Rongxue WuDepartment of Medicine, Section of Cardiology, University of Chicago, Chicago, USA.
Edward N HarrisDepartment of Biochemistry, University of Nebraska-Lincoln, Lincoln, NE, 68583, USA.
Qiaozhu SuInstitute for Global Food Security, School of Biological Sciences, Queen's University Belfast, Belfast, BT9 5DL, UK. q.su@qub.ac.uk.
Queen's University Belfast · GBUniversity of Nebraska–Lincoln · USUniversity of Chicago · USUniversity of Nebraska Medical Center · US

Funding

Metabolism of Antisense Oligonucleotides and other Polyanions in LiverR01GM147913 · NIGMS · UNIVERSITY OF NEBRASKA LINCOLN · PI HARRIS, EDWARD N · 2022 to 2025
$1.3M
British Heart Foundation PG/19/86/34788NIGMS NIH HHS R01 GM147913NIH HHS R01 GM147913
6 · The paper itself

Abstract

backgroundThe intestinal epithelial barrier is the interface for interaction between gut microbiota and host metabolic systems. Akkermansia muciniphila (A. muciniphila) is a key player in the colonic microbiota that resides in the mucus layer, whose abundance is selectively decreased in the faecal microbiota of inflammatory bowel disease (IBD) patients. This study aims to investigate the regulatory mechanism among A. muciniphila, a transcription factor cAMP-responsive element-binding protein H (CREBH), and microRNA-143/145 (miR-143/145) in intestinal inflammatory stress, gut barrier integrity and epithelial regeneration.

methodsA novel mouse model with increased colonization of A muciniphila in the intestine of CREBH knockout mice, an epithelial wound healing assay and several molecular biological techniques were applied in this study. Results were analysed using a homoscedastic 2-tailed t-test.

resultsIncreased colonization of A. muciniphila in mouse gut enhanced expression of intestinal CREBH, which was associated with the mitigation of intestinal endoplasmic reticulum (ER) stress, gut barrier leakage and blood endotoxemia induced by dextran sulfate sodium (DSS). Genetic depletion of CREBH (CREBH-KO) significantly inhibited the expression of tight junction proteins that are associated with gut barrier integrity, including Claudin5 and Claudin8, but upregulated Claudin2, a tight junction protein that enhances gut permeability, resulting in intestinal hyperpermeability and inflammation. Upregulation of CREBH by A. muciniphila further coupled with miR-143/145 promoted intestinal epithelial cell (IEC) regeneration and wound repair via insulin-like growth factor (IGF) and IGFBP5 signalling. Moreover, the gene expressing an outer membrane protein of A. muciniphila, Amuc_1100, was cloned into a mammalian cell-expression vector and successfully expressed in porcine and human IECs. Expression of Amuc_1100 in IECs could recapitulate the health beneficial effect of A. muciniphila on the gut by activating CREBH, inhibiting ER stress and enhancing the expression of genes involved in gut barrier integrity and IEC's regeneration.

conclusionsThis study uncovers a novel mechanism that links A. muciniphila and its membrane protein with host CREBH, IGF signalling and miRNAs in mitigating intestinal inflammatory stress-gut barrier permeability and promoting intestinal wound healing. This novel finding may lend support to the development of therapeutic approaches for IBD by manipulating the interaction between host genes, gut bacteria and its bioactive components.

Indexed as

Inflammatory Bowel DiseasesMicroRNAsAkkermansiaAnimalsHumansMammalsMembrane ProteinsMiceSwineVerrucomicrobiaMembrane ProteinsMicroRNAsMIRN143 microRNA, humanAkkermansia muciniphilaAmuc_1100CREBHEpithelial regenerationIntestinal inflammatory stressmicroRNA-143/145Wound healing

Identifiers

PMID37287024
PMCPMC10249216
OpenAlexW4379742493

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.